Elyes M, Heesen P, Schelling G, Bode-Lesniewska B, Studer G, Fuchs B
Cancers (Basel). 2025; 17(3).
PMID: 39941878
PMC: 11816265.
DOI: 10.3390/cancers17030510.
Flyckt R, Sjodsholm L, Henriksen M, Brasen C, Ebrahimi A, Hilberg O
Sci Rep. 2024; 14(1):30630.
PMID: 39719477
PMC: 11668822.
DOI: 10.1038/s41598-024-82093-4.
Matsumoto K, Honda Y, Maeda T, Kumai Y
Cureus. 2024; 16(11):e73253.
PMID: 39655148
PMC: 11625519.
DOI: 10.7759/cureus.73253.
Harvey-Sullivan A, Ali S, Dhesi P, Hart J, Painter H, Walter F
Br J Cancer. 2024; 132(2):158-167.
PMID: 39533108
PMC: 11756392.
DOI: 10.1038/s41416-024-02896-0.
Jensen A, Andersen H, Jensen S, Jensen C, Amstrup J, Mathiasen R
Eur J Haematol. 2024; 114(1):57-69.
PMID: 39295289
PMC: 11613657.
DOI: 10.1111/ejh.14303.
Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
Song K, Shrestha R, Delaney H, Vijjhalwar R, Turner A, Sanchez M
Orphanet J Rare Dis. 2024; 19(1):50.
PMID: 38326833
PMC: 10851567.
DOI: 10.1186/s13023-024-03036-w.
Clinico-Hematological Profile of Acute Myeloid Leukemia: Experience From a Tertiary Care Cancer Center in North India.
Vemprala A, Gajendra S, Gupta R, Thakral D, Bakhshi S, Sahoo R
Cureus. 2024; 15(12):e50869.
PMID: 38249207
PMC: 10799219.
DOI: 10.7759/cureus.50869.
Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold.
Barclay M, Renzi C, Antoniou A, Denaxas S, Harrison H, Ip S
PLOS Digit Health. 2023; 2(12):e0000383.
PMID: 38100737
PMC: 10723831.
DOI: 10.1371/journal.pdig.0000383.
Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis.
Elyes M, Heesen P, Schelling G, Bode-Lesniewska B, Studer G, Fuchs B
Cancers (Basel). 2023; 15(19).
PMID: 37835586
PMC: 10571532.
DOI: 10.3390/cancers15194892.
A taxonomy of early diagnosis research to guide study design and funding prioritisation.
Whitfield E, White B, Denaxas S, Barclay M, Renzi C, Lyratzopoulos G
Br J Cancer. 2023; 129(10):1527-1534.
PMID: 37794179
PMC: 10645731.
DOI: 10.1038/s41416-023-02450-4.
The duration of intervals on the oral cancer care pathway and implications for survival: a systematic review and meta-analysis.
Fernandez-Martinez N, Petrova D, Spacirova Z, Barrios-Rodriguez R, Perez-Sayans M, Martin-delosReyes L
Front Public Health. 2023; 11:1183244.
PMID: 37614446
PMC: 10442570.
DOI: 10.3389/fpubh.2023.1183244.
Patients' Experiences of a Sarcoma Diagnosis: A Process Mapping Exercise of Diagnostic Pathways.
Martin S, Clark S, Gerrand C, Gilchrist K, Lawal M, Maio L
Cancers (Basel). 2023; 15(15).
PMID: 37568761
PMC: 10417695.
DOI: 10.3390/cancers15153946.
The effect of time before diagnosis and treatment on colorectal cancer outcomes: systematic review and dose-response meta-analysis.
Drosdowsky A, Lamb K, Karahalios A, Bergin R, Milley K, Boyd L
Br J Cancer. 2023; 129(6):993-1006.
PMID: 37528204
PMC: 10491798.
DOI: 10.1038/s41416-023-02377-w.
Age and Referral Route Impact the Access to Diagnosis for Women with Advanced Ovarian Cancer.
Norbeck A, Asp M, Carlsson T, Kannisto P, Malander S
J Multidiscip Healthc. 2023; 16:1239-1248.
PMID: 37163196
PMC: 10164381.
DOI: 10.2147/JMDH.S401601.
Model for Achieving a Coordinated Access to Lung Cancer Care in Selected Public Health Facilities in KwaZulu-Natal, South Africa: Protocol for a Qualitative Study.
Lubuzo B, Hlongwana K, Ginindza T
JMIR Res Protoc. 2023; 12:e34341.
PMID: 36867453
PMC: 10024215.
DOI: 10.2196/34341.
Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis.
Papavasiliou E, Sills V, Calanzani N, Harrison H, Snudden C, di Martino E
Cancers (Basel). 2023; 15(3).
PMID: 36765672
PMC: 9913596.
DOI: 10.3390/cancers15030709.
Relationship between ethnicity and stage at diagnosis in England: a national analysis of six cancer sites.
Fry A, White B, Nagarwalla D, Shelton J, Jack R
BMJ Open. 2023; 13(1):e062079.
PMID: 36702581
PMC: 9884890.
DOI: 10.1136/bmjopen-2022-062079.
Improving equity in access to early diagnosis of cancer in different healthcare systems of Latin America: protocol for the EquityCancer-LA implementation-effectiveness hybrid study.
Vazquez M, Vargas I, Rubio-Valera M, Aznar-Lou I, Eguiguren P, Mogollon-Perez A
BMJ Open. 2022; 12(12):e067439.
PMID: 36523219
PMC: 9748968.
DOI: 10.1136/bmjopen-2022-067439.
Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data.
Vedsted P, Weller D, Falborg A, Jensen H, Kalsi J, Brewster D
BMJ Open. 2022; 12(12):e059669.
PMID: 36521881
PMC: 9756230.
DOI: 10.1136/bmjopen-2021-059669.
Being sick to a cancer patient: pathways of delay in help seeking and diagnosis of cancer in India.
George S
J Soc Econ Dev. 2022; 25(1):52-69.
PMID: 36466373
PMC: 9685046.
DOI: 10.1007/s40847-022-00221-0.